299
Participants
Start Date
March 31, 2011
Primary Completion Date
April 30, 2013
Study Completion Date
April 30, 2014
Augment® Injectable Bone Graft
Implantation of up to 9cc of Augment® Injectable Bone Graft
Autologous bone graft
Implantation of up to 9cc of autologous bone graft
Hospital for Special Surgery, New York
University of Rochester Medical Center, Rochester
The Rothman Institute, Philadelphia
Union Memorial Hospital, Baltimore
OrthoCarolina, PA, Charlotte
Campbell Clinic / InMotion Orthopaedic Research Center, Memphis
Orthopedic Foot & Ankle Center, Columbus
Cleveland Clinic Orthopaedic, Cleveland
Mid Michigan Orthopaedic Institute, East Lansing
Orthopaedic Associates of Michigan, PC, Grand Rapids
Illinois Bone & Joint Institute, Ltd., Glenview
Loyola University Medical Center, Maywood
Health Research Institute, Inc., Oklahoma City
Texas Health Research & Education Institute, Dallas
St. Luke's Episcopal Hospital, Houston
Tucson Orthopaedic Research Center, Tucson
University of Arizona, Tucson
Desert Orthopaedic Center, Las Vegas
California Pacific Medical Center, San Francisco
University of Medicine & Dentistry of New Jersey, Newark
Life Mark Health Centre, Calgary
St. Paul's Hospital, Vancouver
Queen Elizabeth II Health Services, Halifax
The Ottawa Hospital, Ottawa
St. Michael's Hospital, Toronto
Lead Sponsor
BioMimetic Therapeutics
INDUSTRY